Market Cap 18.49B
Revenue (ttm) 2.26B
Net Income (ttm) 858.98M
EPS (ttm) N/A
PE Ratio 7.90
Forward PE 7.37
Profit Margin 37.95%
Debt to Equity Ratio 0.78
Volume 2,529,300
Avg Vol 5,380,208
Day's Range N/A - N/A
Shares Out 562.24M
Stochastic %K 67%
Beta 0.49
Analysts Strong Sell
Price Target $41.67

Latest News on RPRX

Royalty Pharma to Present at Upcoming Investor Conferences

May 13, 2025, 8:15 AM EDT - 22 days ago

Royalty Pharma to Present at Upcoming Investor Conferences


Royalty Pharma: Again, Guidance Raised, Buy Confirmed

May 11, 2025, 9:18 PM EDT - 24 days ago

Royalty Pharma: Again, Guidance Raised, Buy Confirmed


Royalty Pharma plc (RPRX) Q1 2025 Earnings Call Transcript

May 8, 2025, 12:44 PM EDT - 27 days ago

Royalty Pharma plc (RPRX) Q1 2025 Earnings Call Transcript


Royalty Pharma Reports First Quarter 2025 Results

May 8, 2025, 7:15 AM EDT - 27 days ago

Royalty Pharma Reports First Quarter 2025 Results


Royalty Pharma Declares Second Quarter 2025 Dividend

Apr 21, 2025, 4:15 PM EDT - 6 weeks ago

Royalty Pharma Declares Second Quarter 2025 Dividend


Royalty Pharma Announces Upcoming Investor Day

Mar 27, 2025, 8:15 AM EDT - 2 months ago

Royalty Pharma Announces Upcoming Investor Day


17 Upcoming Dividend Increases, Including 3 Kings

Feb 13, 2025, 11:03 AM EST - 3 months ago

17 Upcoming Dividend Increases, Including 3 Kings

ADM AFL BKH CTSH ED FBP J


Royalty Pharma: Delivering Growth With A Positive Story Ahead

Feb 12, 2025, 10:02 PM EST - 4 months ago

Royalty Pharma: Delivering Growth With A Positive Story Ahead


Royalty Pharma Announces R&D Funding Collaboration With Biogen

Feb 12, 2025, 6:30 AM EST - 4 months ago

Royalty Pharma Announces R&D Funding Collaboration With Biogen


Royalty Pharma plc (RPRX) Q4 2024 Earnings Call Transcript

Feb 11, 2025, 1:40 PM EST - 4 months ago

Royalty Pharma plc (RPRX) Q4 2024 Earnings Call Transcript


Royalty Pharma Reports Q4 and Full Year 2024 Results

Feb 11, 2025, 7:15 AM EST - 4 months ago

Royalty Pharma Reports Q4 and Full Year 2024 Results


Royalty Pharma: Key Strategic Updates To Be Priced In

Jan 15, 2025, 3:49 AM EST - 5 months ago

Royalty Pharma: Key Strategic Updates To Be Priced In


Royalty Pharma simplifies corporate structure with $1.1 bln deal

Jan 10, 2025, 7:31 AM EST - 5 months ago

Royalty Pharma simplifies corporate structure with $1.1 bln deal


Royalty Pharma Announces Dividend Increase

Jan 9, 2025, 4:15 PM EST - 5 months ago

Royalty Pharma Announces Dividend Increase


Royalty Pharma: Massive Opportunity Ahead

Nov 9, 2024, 12:46 AM EST - 7 months ago

Royalty Pharma: Massive Opportunity Ahead


Royalty Pharma plc (RPRX) Q3 2024 Earnings Call Transcript

Nov 6, 2024, 12:28 PM EST - 7 months ago

Royalty Pharma plc (RPRX) Q3 2024 Earnings Call Transcript


Royalty Pharma Reports Third Quarter 2024 Results

Nov 6, 2024, 7:15 AM EST - 7 months ago

Royalty Pharma Reports Third Quarter 2024 Results


Royalty Pharma Declares Fourth Quarter 2024 Dividend

Oct 11, 2024, 8:15 AM EDT - 8 months ago

Royalty Pharma Declares Fourth Quarter 2024 Dividend


Royalty Pharma plc Q2: Beat And Raise Reaffirm Our Buy Rating

Aug 22, 2024, 3:04 AM EDT - 10 months ago

Royalty Pharma plc Q2: Beat And Raise Reaffirm Our Buy Rating


Royalty Pharma: Busy Putting Capital To Work

Aug 11, 2024, 6:33 PM EDT - 10 months ago

Royalty Pharma: Busy Putting Capital To Work


Royalty Pharma plc (RPRX) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 2:14 PM EDT - 10 months ago

Royalty Pharma plc (RPRX) Q2 2024 Earnings Call Transcript


Royalty Pharma Declares Third Quarter 2024 Dividend

Jul 17, 2024, 4:15 PM EDT - 11 months ago

Royalty Pharma Declares Third Quarter 2024 Dividend


Royalty Pharma PLC (RPRX) Q1 2024 Earnings Call Transcript

May 9, 2024, 1:32 PM EDT - 1 year ago

Royalty Pharma PLC (RPRX) Q1 2024 Earnings Call Transcript